<DOC>
	<DOC>NCT01569113</DOC>
	<brief_summary>The purposes of this study are to compare the effects on ovarian activity of quick starting a Combined Oral Contraceptive Pill (COCP) after ellaOne® or placebo intake.</brief_summary>
	<brief_title>Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Contraceptives, Oral, Combined</mesh_term>
	<criteria>Healthy women aged 1835 years old BMI &lt; 30 Kg/m2 Not at risk of pregnancy No use of progesteroneonlypill for 3 months before start of treatment cycle No use of implant hormonal contraception for 3 months before start of treatment cycle No use of levonorgestrel intrauterine system for 3 months before start of treatment cycle No use of depo provera for 12 months before start of treatment cycle Able to give informed consent.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>ella</keyword>
	<keyword>ellaOne</keyword>
	<keyword>quickstart</keyword>
	<keyword>contraception</keyword>
	<keyword>combined oral pill</keyword>
	<keyword>microgynon</keyword>
</DOC>